| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 07/23/2008 | EP1946007A2 Anbrosteeone derivatives and method of use thereof |
| 07/23/2008 | EP1945767A1 Identification and characterization of function-blocking anti-ed-b-fibronectin antibodies |
| 07/23/2008 | EP1945674A2 Therapeutic anti-her2 antibody fusion polypeptides |
| 07/23/2008 | EP1945671A2 Generation and profiling of fully human hucal gold-derived therapeutic antibodies specific for human cd38 |
| 07/23/2008 | EP1945665A2 Antibody-based therapeutics with enhanced adcc activity |
| 07/23/2008 | EP1945644A2 Imidazopyrazines as protein kinase inhibitors |
| 07/23/2008 | EP1945643A2 Imidazopyrazines as cyclin dependent kinase inhibitors |
| 07/23/2008 | EP1945637A1 5-oxo-5,8-dihydro-pyrido-pyrimidines as inhibitors of c-fms kinase |
| 07/23/2008 | EP1945631A1 4- (3-aminopyrazole) pyrimidine derivatives for use as tyrosine kinase inhibitors in the treatment of cancer |
| 07/23/2008 | EP1945627A1 Pyrimidine derivatives for the treatment of cancer |
| 07/23/2008 | EP1945617A2 Histone deacetylase inhibitors with aryl-pyrazolyl motifs |
| 07/23/2008 | EP1945612A2 Heterocyclic compounds as pstat3/il-6 inhibitors |
| 07/23/2008 | EP1945606A1 Alkylcarbamoyl naphthalenyloxy- octenoylhydroxyamide derivatives having inhibitory activity against histone deacetylase and preparation thereof |
| 07/23/2008 | EP1945266A1 Methods of modulating apoptosis and platelet production using variants of cytochrome c |
| 07/23/2008 | EP1945265A1 Antiproliferative combination comprising cyc-682 and a cytotoxic agent |
| 07/23/2008 | EP1945232A2 Anti-proliferative combination therapy using certain platinum-based chemotherapeutic agents and egfr inhibitors or pyrimidine analogues |
| 07/23/2008 | EP1945224A1 Reduction of side effects from aromatase inhibitors used for treating breast cancer |
| 07/23/2008 | EP1945222A2 Pyrrolo[2,1-f] [1,2,4] triazin-4-ylamines igf-1r kinase inhibitors for the treatment of cancer and other hyperproliferative diseases |
| 07/23/2008 | EP1945219A2 Compound |
| 07/23/2008 | EP1945216A1 Methods for inhibiting protein kinases |
| 07/23/2008 | EP1945202A2 Mammalian hedgehog signaling inhiabitors |
| 07/23/2008 | EP1945195A2 Novel use of a nutraceutical composition comprising resveratrol for the treatment of age-related diseases |
| 07/23/2008 | EP1761525B1 Thioether derivatives, their manufacture and use as pharmaceutical agents |
| 07/23/2008 | EP1671949B1 Substituted Pyridinylamines |
| 07/23/2008 | EP1635840B1 Thiophenepyrimidinones as 17-beta-hydroxysteroid dehydrogenase inhibitors |
| 07/23/2008 | EP1572194B1 Anti-cancer composition comprising dmxaa |
| 07/23/2008 | EP1565195B1 Anticancer or antiviral composition |
| 07/23/2008 | EP1523988B1 Composition comprising radix codonopsis pilosulae and radix astragali for the treatment of acute lung injury |
| 07/23/2008 | EP1490367B1 Imidazopyridine derivatives as kinase inhibitors |
| 07/23/2008 | EP1401426B1 Ptpase inhibitors and method of using same |
| 07/23/2008 | EP1382603B1 Nitrogenous fused-ring compound having pyrazolyl group as substituent and medicinal composition thereof |
| 07/23/2008 | EP1372696B1 Methods for treating rheumatic diseases using a soluble ctla4 molecule |
| 07/23/2008 | EP1356030B1 Runx3 gene showing anti-tumor activity and use thereof |
| 07/23/2008 | EP1328287B1 Compositions and methods for wt1 specific immunotherapy |
| 07/23/2008 | EP1315715B1 Quinazoline derivatives as kinase inhibitors |
| 07/23/2008 | EP1248841B1 Genes differentially expressed in breast cancer |
| 07/23/2008 | EP1239829B1 Devices for the delivery of drugs having antiprogestinic properties |
| 07/23/2008 | EP1218369B1 INHIBITORS OF c-JUN N-TERMINAL KINASES (JNK) AND OTHER PROTEIN KINASES |
| 07/23/2008 | EP1141241B1 Adult human astrocytes, preparation of the same, and uses thereof |
| 07/23/2008 | EP1085876B1 Pharmaceutical composition with tumor necrosis factor a and 2-methoxyestrone-3-o-sulphamate for inhibition of estrone sulphatase |
| 07/23/2008 | EP1080092B1 Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidines as inhibitors of cellular proliferation |
| 07/23/2008 | EP1071680B1 N,n-disubstituted amides that inhibit the binding of integrins to their receptors |
| 07/23/2008 | EP1047416B1 Pharmaceutical compositions comprising disulfiram for inhibiting angiogenesis |
| 07/23/2008 | EP1044199B1 Heterocyclic topoisomerase poisons |
| 07/23/2008 | CN101228167A Pyrazolo[1,5-a]pyrimidin-7-yl amine derivatives as protein kinase inhibitors |
| 07/23/2008 | CN101228161A Pyrrolopyridines useful as inhibitors of protein kinase |
| 07/23/2008 | CN101228160A Azaindoles useful as inhibitors of protein kinases |
| 07/23/2008 | CN101228151A Salts of 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidine-2-ylamino)-benzamide |
| 07/23/2008 | CN101228150A Crystalline forms of 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide |
| 07/23/2008 | CN101228125A Cathepsin K inhibitors |
| 07/23/2008 | CN101227909A Combination comprising a pyrimidylaminobenzamides and a Flt-3 inhibitor for treating proliferative diseases |
| 07/23/2008 | CN101227906A Antiproliferative drug |
| 07/23/2008 | CN101225403A Small interfering RNA recombinant adenovirus for targeting epidermal growth factor receptor and use thereof |
| 07/23/2008 | CN101225397A Construction of fusion gene pronucleus vector for IL-24 and EGF and uses thereof |
| 07/23/2008 | CN101225391A Recombinant human interferon regulatory factor 4 binding protein expression system as well as preparation method and uses thereof |
| 07/23/2008 | CN101225383A RNA interference sequence and recombinant interference plasmid of fucosyl transferase I and IV for suppressing synthesis of LeY carbohydrate antigen |
| 07/23/2008 | CN101225109A Tumour soluble antigen and staphylococcus aureus superantigen constructed tumor vaccine |
| 07/23/2008 | CN101225106A Short peptide suppressing growth of cancer cell and uses thereof |
| 07/23/2008 | CN101225098A Nucleic acid molecule CRYL1SI2 and application for preparation of anti-cancer drugs |
| 07/23/2008 | CN101225097A Nucleic acid molecule CRYL1SI22 and application for preparation of anti-cancer drugs |
| 07/23/2008 | CN101225094A Anthraquinones tetracyclic compound having anticancer activity |
| 07/23/2008 | CN101225092A Manganese complex as well as preparation method and uses thereof |
| 07/23/2008 | CN101225085A Phenyl urazan nitrogen nitric oxide donor 2-aniline pyrimidine derivatives, preparation method, compound containing the same and use thereof |
| 07/23/2008 | CN101225070A Antineoplastic medicament |
| 07/23/2008 | CN101225066A Cyclohexenone extract of antrodia camphorata |
| 07/23/2008 | CN101225049A Beta-elemene amino acid derivatives as well as synthetic method and use thereof |
| 07/23/2008 | CN101225040A Method for extracting crocetin from gardenia |
| 07/23/2008 | CN101225031A Disubstituted allyl benzene derivatives as well as preparation and uses thereof |
| 07/23/2008 | CN101224307A Acute progranulocyte leukemia DNA vaccine PML-RAR alpha 384-hIL-2 and preparing method and application thereof |
| 07/23/2008 | CN101224306A Folic acid-polypeptide compound-mediated targeting anti-tumor prodrug and preparing method thereof |
| 07/23/2008 | CN101224299A Preparing method of compounds capable of inducing tumor cell apoptosis |
| 07/23/2008 | CN101224295A Chinese traditional medicine compounds for treating digestive system tumor and preparing method thereof |
| 07/23/2008 | CN101224294A Clinical application of Chinese herbs for treating liver cancer |
| 07/23/2008 | CN101224257A Polypeptide soft capsule without free radical and preparing method thereof |
| 07/23/2008 | CN101224254A Capsicum uses |
| 07/23/2008 | CN101224237A Novel uses of compound seabuckthorn seed oil in preparing medicine |
| 07/23/2008 | CN101224225A Preparing method of hypericum perforatum extract |
| 07/23/2008 | CN101224219A Medicine compounds for anti-tumor |
| 07/23/2008 | CN101224216A Medicine compounds for anti-tumor |
| 07/23/2008 | CN101224215A Uses of ursolic acid saponin and oleanolic acid saponin in preparing medicine for increasing white blood cell and/or blood platelet |
| 07/23/2008 | CN101224203A Tanshinone IIA microemulsions and preparing method thereof |
| 07/23/2008 | CN101224193A Compound sustained release injection containing newborn blood vessel inhibitor and cytotoxic drugs |
| 07/23/2008 | CN101224192A Injection containing newborn blood vessel inhibitor |
| 07/23/2008 | CN101224191A Compound sustained release injection containing newborn blood vessel inhibitor |
| 07/23/2008 | CN101224190A Compound sustained release injection containing newborn blood vessel inhibitor fumagillin |
| 07/23/2008 | CN101224189A Sustained release injection containing newborn blood vessel inhibitor |
| 07/23/2008 | CN101224188A Compound sustained release injection containing newborn blood vessel inhibitor marimastat |
| 07/23/2008 | CN101224185A Bosutinib sustained release implant for treating solid tumors |
| 07/23/2008 | CN100404683C Human FL polynucleotide and use of human GM-CSF united gene therewith for treating malignant tumor |
| 07/23/2008 | CN100404537C Quinazolin allkaloids compound, preparation method and use thereof |
| 07/23/2008 | CN100404528C Novel pyrimidineamide derivatives and the use thereof |
| 07/23/2008 | CN100404524C High purity cnidicin and its preparation method and medicinal composition using said compound as active component |
| 07/23/2008 | CN100404517C Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof |
| 07/23/2008 | CN100404075C Preparation method of interpose internal radiation anti tumour series medicine |
| 07/23/2008 | CN100404070C Packaged virus-like particles |
| 07/23/2008 | CN100404034C An agent for controlling Bc1-2 expression comprising ginsenoside F1 as an active component |
| 07/23/2008 | CN100404032C Novel crystalline forms of the anti-cancer compound ZD1839 |
| 07/23/2008 | CN100404023C Elemene soft capsule and its preparation process |
| 07/23/2008 | CN100404019C Multivesicular emulsion topical delivery systems |
| 07/23/2008 | CN100403979C Method and device for measuring body composition |